DZ2934A1 - Nouveaux composés de pipérazine et de pipéridine. - Google Patents

Nouveaux composés de pipérazine et de pipéridine.

Info

Publication number: DZ2934A1
Authority: DZ; Algeria
Prior art keywords: piperidine compounds; new piperazine; piperazine; new; piperidine
Prior art date: 1998-11-13

Application number

DZ990234A

Other languages

English (en)

Inventor

Roelof W Feenstra

Van Der Johannes A M Heijden

Johannes Mos

Stephen K Long

Gerben M Visser

Cornelis G Kruse

Gustaaf J M Scharrenburg

Gerrit P Toorop

Original Assignee

Duphar Int Res

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-11-13

Filing date

1999-11-10

Publication date

2004-03-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8234340&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DZ2934(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-11-10 Application filed by Duphar Int Res filed Critical Duphar Int Res

2004-03-15 Application granted granted Critical

2004-03-15 Publication of DZ2934A1 publication Critical patent/DZ2934A1/fr

Links

GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 title 2
150000003053 piperidines Chemical class 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/26—Oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Psychology (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

DZ990234A 1998-11-13 1999-11-10 Nouveaux composés de pipérazine et de pipéridine. DZ2934A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP98203871		1998-11-13

Publications (1)

Publication Number	Publication Date
DZ2934A1 true DZ2934A1 (fr)	2004-03-15

Family

ID=8234340

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DZ990234A DZ2934A1 (fr)	1998-11-13	1999-11-10	Nouveaux composés de pipérazine et de pipéridine.

Country Status (27)

Country	Link
US (1)	US6780864B1 (fr)
EP (1)	EP1131308B1 (fr)
JP (1)	JP3638874B2 (fr)
KR (1)	KR100619465B1 (fr)
CN (1)	CN1225462C (fr)
AR (1)	AR021256A1 (fr)
AT (1)	ATE267183T1 (fr)
AU (1)	AU756470B2 (fr)
BR (1)	BR9915293B1 (fr)
CA (1)	CA2350137C (fr)
CZ (1)	CZ299774B6 (fr)
DE (1)	DE69917478T2 (fr)
DK (1)	DK1131308T3 (fr)
DZ (1)	DZ2934A1 (fr)
ES (1)	ES2217833T3 (fr)
HU (1)	HUP0104922A3 (fr)
IL (2)	IL143028A0 (fr)
MX (1)	MXPA01004854A (fr)
NO (1)	NO318888B1 (fr)
NZ (1)	NZ511584A (fr)
PL (1)	PL193685B1 (fr)
RU (1)	RU2225406C2 (fr)
SI (1)	SI1131308T1 (fr)
SK (1)	SK285648B6 (fr)
TW (1)	TWI252230B (fr)
UA (1)	UA71590C2 (fr)
WO (1)	WO2000029397A1 (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
UA73981C2 (en)	2000-03-10	2005-10-17	Merck Patent Gmbh	(r)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane for treatment of extrapyramidal movement disorders (variants), pharmaceutical composition and kit
US20030186838A1 (en) *	2000-05-12	2003-10-02	Feenstra Roelof W.	Use of compounds having combined dopamine d2, 5-ht1a and alpha adrenoreceptor agonistic action for treating cns disorders
AU6392701A (en) *	2000-05-12	2001-11-20	Solvay Pharm Bv	Piperazine and piperidine compounds
CA2428519A1 (fr) *	2000-11-14	2002-05-23	Merck Patent Gesellschaft Mit Beschraenkter Haftung	Nouvelles utilisations de l'antagoniste combines selectif du recepteur d2 de la dopamine et de l'agoniste du recepteur de la 5-ht1a
AR034206A1 (es) *	2001-02-16	2004-02-04	Solvay Pharm Bv	Un procedimiento para la preparacion de mesilatos de derivados de piperazina y dichos mesilatos
US6800648B2 (en)	2001-04-26	2004-10-05	Wyeth	Antipsychotic aminomethyl derivatives of 7,8-dihydro-3H-1,6,9-trioxa-3-AZA-cyclopenta[a]naphthalen-2-one
US6743796B2 (en) *	2001-05-07	2004-06-01	Wyeth	Piperazinyl-isatins
US7504395B2 (en)	2001-07-20	2009-03-17	Psychogenics, Inc.	Treatment for attention-deficit hyperactivity disorder
ATE352302T1 (de)	2001-07-26	2007-02-15	Merck Patent Gmbh	Verwendung von 2- 5-(4-fluorphenyl)-3- pyridylmethylaminomethyl-chroman und seiner physiologisch annehmbaren salze
EP1336406A1 (fr) *	2002-02-14	2003-08-20	Solvay Pharmaceuticals B.V.	Agonistes partiels du récepteur D2 de la dopamine et inhibiteurs de la sérotonine et/ou de la noradrénaline
WO2004000837A1 (fr) *	2002-06-25	2003-12-31	Sumitomo Pharmaceuticals Co., Ltd.	Nouveau derive de benzoxazolinone
US7435738B2 (en)	2003-08-18	2008-10-14	Solvay Pharmaceuticals, Inc.	Stable crystalline form of bifeprunox mesylate (7-[4-([1,1′-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate)
EP1595542A1 (fr) *	2004-03-26	2005-11-16	Solvay Pharmaceuticals B.V.	Administration iontophoretique de composés piperazinyl-2(3h)-benzoxazoloniques
US7596407B2 (en)	2004-03-26	2009-09-29	Solvay Pharmaceuticals, B.V.	Transdermal iontophoretic delivery of piperazinyl-2(3H)-benzoxazolone compounds
ES2332597T3 (es)	2004-05-27	2010-02-09	Ucb Pharma S.A.	Derivados de benzoxazolona, procedimientos para su preparacion y su uso.
US7405216B2 (en)	2004-08-18	2008-07-29	Solvay Pharmaceuticals, B.V.	Stable crystalline form of bifeprunox mesylate (7-[4-([1,1′-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate)
US7964604B2 (en)	2005-02-18	2011-06-21	Solvay Pharmaceuticals B.V.	Bifeprunox mesylate maintenance dose compositions and methods for using the same
US7423040B2 (en)	2005-02-18	2008-09-09	Irene Eijgendaal	Stable crystalline form of bifeprunox mesylate, dosage forms thereof and methods for using same
US7750013B2 (en)	2005-08-22	2010-07-06	Solvay Pharmaceuticals, B.V.	N-oxides as prodrugs of piperazine and piperidine derivatives
AR058022A1 (es) *	2005-08-22	2008-01-23	Solvay Pharm Bv	Derivados de benzooxazoles, composiciones farmaceuticas y su uso para el tratamiento de desordenes del sistema nervioso.
JP2009504799A (ja) *	2005-08-22	2009-02-05	ソルベイ・フアーマシユーチカルズ・ベー・ブイ	ピペラジンおよびピペリジン誘導体のプロドラッグとしてのｎ−オキシド
US8106056B2 (en)	2006-06-16	2012-01-31	Solvay Pharmaceuticals B.V.	Combination preparations comprising bifeprunox and a dopamine agonist
US7786126B2 (en)	2006-06-16	2010-08-31	Solvay Pharmaceuticals B.V.	Combination preparations comprising SLV308 and a dopamine agonist
UY32935A (es) *	2009-10-12	2011-05-31	Abbott Healthcare Products Bv	Polimorfos de pardoprunox
CA3034895A1 (fr)	2016-08-26	2018-03-01	Exciva Ug (Haftungsbeschrankt)	Compositions et procedes associes

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2567884B1 (fr)	1984-07-19	1987-03-06	Roussel Uclaf	Nouveaux derives de l'indole, leur preparation, leur application comme medicaments et les compositions les renfermant
EP0185429A1 (fr) *	1984-12-21	1986-06-25	Duphar International Research B.V	Pipérazines bicycliques
ATE81975T1 (de) *	1984-12-21	1992-11-15	Duphar Int Res	Arzneimittel mit psychotroper wirkung.
DK148392D0 (da) *	1992-12-09	1992-12-09	Lundbeck & Co As H	Heterocykliske forbindelser
ZA954689B (en)	1994-06-08	1996-01-29	Lundbeck & Co As H	4-Aryl-1-(indanmethyl dihydrobenzofuranmethyl or dihydrobenzothiophenemethyl) piperidines tetrahydropyridines or piperazines
CA2194984C (fr) *	1994-07-26	2002-07-02	John Eugene Macor	Derives 4-indole utilises comme agonistes et antagonistes de la serotonine
PT889889E (pt) *	1996-03-29	2007-01-31	Duphar Int Res	Composto de piperazina e piperidina
EP0900792B1 (fr)	1997-09-02	2003-10-29	Duphar International Research B.V	Dérivés de pipéridine et de pipérazine comme agonistes du récepteur 5-HT1

1999
- 1999-10-11 UA UA2001064076A patent/UA71590C2/uk unknown
- 1999-11-10 EP EP99955980A patent/EP1131308B1/fr not_active Expired - Lifetime
- 1999-11-10 KR KR1020017005978A patent/KR100619465B1/ko not_active Expired - Fee Related
- 1999-11-10 MX MXPA01004854A patent/MXPA01004854A/es not_active IP Right Cessation
- 1999-11-10 CA CA002350137A patent/CA2350137C/fr not_active Expired - Fee Related
- 1999-11-10 WO PCT/EP1999/008702 patent/WO2000029397A1/fr not_active Ceased
- 1999-11-10 SK SK649-2001A patent/SK285648B6/sk not_active IP Right Cessation
- 1999-11-10 PL PL99347635A patent/PL193685B1/pl not_active IP Right Cessation
- 1999-11-10 ES ES99955980T patent/ES2217833T3/es not_active Expired - Lifetime
- 1999-11-10 CN CNB998130710A patent/CN1225462C/zh not_active Expired - Fee Related
- 1999-11-10 AT AT99955980T patent/ATE267183T1/de active
- 1999-11-10 US US09/831,149 patent/US6780864B1/en not_active Expired - Fee Related
- 1999-11-10 HU HU0104922A patent/HUP0104922A3/hu unknown
- 1999-11-10 JP JP2000582384A patent/JP3638874B2/ja not_active Expired - Fee Related
- 1999-11-10 DK DK99955980T patent/DK1131308T3/da active
- 1999-11-10 DE DE69917478T patent/DE69917478T2/de not_active Expired - Lifetime
- 1999-11-10 RU RU2001116117/04A patent/RU2225406C2/ru not_active IP Right Cessation
- 1999-11-10 BR BRPI9915293-2A patent/BR9915293B1/pt not_active IP Right Cessation
- 1999-11-10 NZ NZ511584A patent/NZ511584A/xx not_active IP Right Cessation
- 1999-11-10 CZ CZ20011657A patent/CZ299774B6/cs not_active IP Right Cessation
- 1999-11-10 SI SI9930574T patent/SI1131308T1/xx unknown
- 1999-11-10 AU AU12709/00A patent/AU756470B2/en not_active Ceased
- 1999-11-10 DZ DZ990234A patent/DZ2934A1/fr active
- 1999-11-10 IL IL14302899A patent/IL143028A0/xx active IP Right Grant
- 1999-11-12 AR ARP990105763A patent/AR021256A1/es active IP Right Grant
2000
- 2000-01-05 TW TW089100097A patent/TWI252230B/zh not_active IP Right Cessation
2001
- 2001-05-08 IL IL143028A patent/IL143028A/en not_active IP Right Cessation
- 2001-05-11 NO NO20012339A patent/NO318888B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
AU756470B2 (en)	2003-01-16
IL143028A0 (en)	2002-04-21
CA2350137A1 (fr)	2000-05-25
AU1270900A (en)	2000-06-05
AR021256A1 (es)	2002-07-03
KR100619465B1 (ko)	2006-09-05
JP3638874B2 (ja)	2005-04-13
EP1131308A1 (fr)	2001-09-12
NZ511584A (en)	2003-01-31
DK1131308T3 (da)	2004-06-28
IL143028A (en)	2006-12-10
US6780864B1 (en)	2004-08-24
NO318888B1 (no)	2005-05-18
PL347635A1 (en)	2002-04-22
KR20010080995A (ko)	2001-08-25
TWI252230B (en)	2006-04-01
ATE267183T1 (de)	2004-06-15
JP2002530276A (ja)	2002-09-17
BR9915293B1 (pt)	2011-11-01
CZ299774B6 (cs)	2008-11-19
RU2225406C2 (ru)	2004-03-10
SK6492001A3 (en)	2001-10-08
CA2350137C (fr)	2008-04-22
NO20012339D0 (no)	2001-05-11
DE69917478D1 (de)	2004-06-24
SI1131308T1 (en)	2004-10-31
UA71590C2 (en)	2004-12-15
HUP0104922A2 (en)	2002-08-28
NO20012339L (no)	2001-05-11
WO2000029397A1 (fr)	2000-05-25
HUP0104922A3 (en)	2003-05-28
CZ20011657A3 (cs)	2001-10-17
HK1039489A1 (en)	2002-04-26
ES2217833T3 (es)	2004-11-01
CN1225462C (zh)	2005-11-02
EP1131308B1 (fr)	2004-05-19
BR9915293A (pt)	2001-08-07
SK285648B6 (sk)	2007-05-03
CN1378540A (zh)	2002-11-06
DE69917478T2 (de)	2004-09-16
PL193685B1 (pl)	2007-03-30
MXPA01004854A (es)	2005-07-25

Publication	Publication Date	Title
DZ2613A1 (fr)	2003-03-01	Nouveaux composés de pipérazine et de pipéridine.
ID17259A (id)	1997-12-11	Fluorina mengandung turunan piperidina 1,4-disubtitusikan
DE69940898D1 (de)	2009-06-25	Bohrverfahren
ID29241A (id)	2001-08-16	Turunan-turunan kinolin teranelasi-1,2
ID29066A (id)	2001-07-26	Turunan fenilglisina
ID27423A (id)	2001-04-05	Turunan kuinolin
DE59909242D1 (de)	2004-05-27	Referenzelektrode
DE59910960D1 (de)	2004-12-09	Bohrwerkzeug
ID23234A (id)	2000-03-30	Turunan-turunan benzosulfona
ID27484A (id)	2001-04-12	Turunan adenosina
PT1089996E (pt)	2004-02-27	Metanossulfonato de paroxetina
DE69826891D1 (de)	2004-11-11	Piperidinderivate
ID27547A (id)	2001-04-12	Turunan kuinolin
DE69913633D1 (de)	2004-01-29	Rohrschneider
EP1124578A4 (fr)	2005-01-19	Nouveaux immunoadjuvants
DK1131308T3 (da)	2004-06-28	Piperazin- og piperidinderivater
ID26909A (id)	2001-02-15	Turunan-turunan 1,3,4-oksadiazolon
FR2758327B1 (fr)	1999-04-02	Nouvelles arylpiperazines derivees de piperidine
DE69903495D1 (de)	2002-11-21	Rohrschneider
DK1149106T3 (da)	2003-07-14	4,5-azolo-oxindoler
TR199902839A3 (tr)	2000-09-21	Yeni 4-ikameli piperidinler.
DE69925408D1 (de)	2005-06-30	Bohrwerkzeug
DE69917909D1 (de)	2004-07-15	Elektroden
FI980759A0 (fi)	1998-04-02	Taetningskonstruktion foer suglaodan i en sugvals
ID28356A (id)	2001-05-17	Turunam tiazola